English
Opaxol 300 mgI/mL IA/IV/Intrathecal Injection Solution
Qualitative and Quantitative Composition:
Each mL contains 647 mg iohexol, equivalent to 300 mg iodine, as the active substance, and trometamol, sodium calcium edetate, hydrochloric acid, and water for injection as excipients.
Non-ionic, monomeric, X-ray contrast agent
Commercial Presentations:
1x50 mL Vial
1x100 mL Vial
If you wish to report a side effect/adverse reaction related to the product, please fill out the TÜFAM reporting form and send it to opakim@deltapv.com.tr. Click here to download the TÜFAM reporting form.
Opaxol 350 mgI/mL IA/IV Injection Solution
Qualitative and Quantitative Composition:
Each mL contains 755 mg iohexol, equivalent to 350 mg iodine, as the active substance, and trometamol, sodium calcium edetate, hydrochloric acid and/or sodium hydroxide, and water for injection as excipients.
Non-ionic, monomeric, X-ray contrast agent
Commercial Presentations:
1x50 mL Vial
1x100 mL Vial
1x200 mL Vial
If you wish to report a side effect/adverse reaction related to the product, please fill out the TÜFAM reporting form and send it to opakim@deltapv.com.tr. Click here to download the TÜFAM reporting form.
